13/05/2021

Mechanisms of KRAS signaling in lung cancer development

Dr. Matthias Drosten — Centro Nacional de Investigaciones Oncológicas CNIO

27/05/2021

Receptor nanoclustering modulates chemokine responses

Mario Mellado Alonso — Centro Nacional de Biotecnología (CNB)

03/06/2021

VRK1-mediated regulation of Tip60/KAT5 acetyltransferase during DDR

Raúl García — Centro de Investigación del Cáncer (CIC-IBMCC)

10/06/2021

Novel mechanisms controlling KRAS oncogenic output: impact on tumour fitness and cancer vulnerabilities

David Santamaría — University of Bordeaux, France

15/06/2021

Addressing the true complexity of biology with 10x Genomics single cell and spatial multiomics

Luca Mazzitelli , 10x Genomics — 10x Genomics

24/06/2021

Control of Actin Polymerization in Cells Through Activation and Inhibition of the Arp2/3 Complex

Roberto Domínguez — Department of Physiology. University of Pennsylvania. Perelman School of Medicine (Philadelphia, USA)

01/07/2021

Role of RRAS2 as an oncogenic driver

Laura Clavaín — Centro de Investigación del Cáncer (CIC-IBMCC)

06/05/2021

Critical requirement of SOS1 RAS-GEF function for mitochondrial dynamics, metabolism and redox homeostasis

Rósula García Navas — Centro de Investigación del Cáncer (CIC-IBMCC)

29/04/2021

tRNA biology in health and disease: from expanding proteome diversity to promising biomarkers in medicine

Adrián Gabriel Torres — Institut de Recerca Biomèdica de Barcelona

22/04/2021

Deep learning and bioinformatics on human large-scale transcriptomic data: studies of neurodegeneration and cancer

Óscar González-Velasco — Centro de Investigación del Cáncer (CIC-IBMCC)

15/04/2021

Decoding the epitranscriptome at single molecule resolution

Eva Novoa — Center for Genomic Regulation (CRG) de Barcelona